Skip to main content
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleImaging

Effective Dose in Nuclear Medicine Studies and SPECT/CT: Dosimetry Survey Across Quebec Province

Mathieu Charest and Chantal Asselin
Journal of Nuclear Medicine Technology June 2018, 46 (2) 107-113; DOI: https://doi.org/10.2967/jnmt.117.202879
Mathieu Charest
1Nuclear Medicine Service, Hôpital du Sacré-Cœur de Montréal, Montreal, Quebec, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal Asselin
2Collège Ahuntsic, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    2014 survey results: distribution of administered activity and effective doses in selected nuclear medicine studies. MUGA = multigated acquisition; DMSA = dimercaptosuccinic acid; MAG3 = mercaptoacetyltriglycine; MAA = macroaggregated albumin; RBC = red blood cells; HMPAO = hexamethylpropyleneamine oxime; ECD = ethyl cysteinate dimer.

Tables

  • Figures
    • View popup
    TABLE 1

    2014 and 2010 Survey Results on Administered Activity and Effective Dose in Selected Nuclear Medicine Studies

    2014 survey results2010 survey results
    Activity (MBq)Dose (mSv)Activity (MBq)Dose (mSv)
    StudyTracerCenters (n)MinMaxMeanSDDRL (MBq)Factor (mSv/MBq)MeanSDDRL (mSv)MeanSDMeanSDP
    Cardiovascular
     Myocardial kinetic (MUGA)99mTc-RBC22740.01480.01139.3192.31,295.00.00708.01.49.11,177.7163.78.21.20.4532
     Myocardial perfusion–rest99mTc-sestamibi16370.01,110.0854.9220.8980.80.00907.72.08.8969.9276.28.72.5
     Myocardial perfusion–rest99mTc-tetrofosmin5444.0925.0777.0217.3925.00.00806.21.77.4
     Myocardial perfusion–stress99mTc-sestamibi16555.01,295.0933.5180.91,054.50.00797.41.48.31,059.8196.08.41.6
     Myocardial perfusion–stress99mTc-tetrofosmin5666.01,221.0932.4196.5925.00.00696.41.46.4
     Myocardial perfusion–totalCombined values2114.52.715.618.33.90.0002
    Musculoskeletal
     Whole-body scan
      Bone scan99mTc-MDP22740.01,110.0996.8100.11,110.00.00494.90.55.4999.7124.34.90.60.9255
      Infection scan67Ga-citrate21185.0370.0261.650.5296.00.100026.25.029.6310.061.331.06.10.0037
     Extremities only
      Bone scan99mTc-MDP22925.01,295.01,022.0102.21,110.00.00495.00.55.4
      Infection scan67Ga-citrate21111.0259.0177.134.4185.00.100017.73.418.5
    Endocrinology
     Thyroid uptake131I-sodium iodine210.192.220.880.661.112219.414.524.40.80.618.512.40.8136
     Thyroid scan99mTc-pertechnetate21296.0740.0415.8109.7370.00.01305.41.44.8425.5102.75.51.30.7516
     Parathyroid scan99mTc-sestamibi21555.01,295.0946.9204.51,110.00.00908.51.810.0867.5196.77.81.80.1730
    Nephrourology
     Renal cortex99mTc-DMSA22111.0740.0208.5122.7185.00.00881.81.11.6198.050.41.70.40.7082
     Renal scan with MAG399mTc-MAG322185.0555.0336.4111.2370.00.00702.40.82.6324.8113.82.30.80.7214
    Pulmonary
     Perfusion scan99mTc-MAA22185.0370.0274.868.3296.00.01103.00.83.3244.356.52.690.620.1144
     Aerosols (10% inhaled)99mTc-aerosols370.3148.0109.838.9129.50.01401.50.51.8102.131.01.40.40.7831
     Technegas* (10% inhaled)99mTc-Technegas*1936.476.756.920.174.00.01500.90.31.153.917.80.80.30.2267
    Digestive
     Hepatobiliary (HIDA scan)99mTc-HIDA analogs22185.0370.0222.059.3222.00.01603.60.93.6242.169.83.91.10.2681
     Liver hemangioma scan99mTc-RBC22740.01,480.01,122.5157.11,177.50.00707.91.18.21,125.4220.57.91.50.9568
     Liver and spleen scan99mTc-sulfur colloid22185.0555.0282.591.0323.80.00912.60.82.9279.659.82.50.50.8961
    Neurology
     Perfusion scan99mTc-HMPAO6925.01,110.01,048.395.51,110.00.00939.70.910.3970.9209.39.01.90.3756
     Perfusion scan99mTc-ECD7925.01,110.01,057.190.31,110.00.00778.10.78.51,118.1144.08.61.10.2517
     Glucose metabolism18F-FDG4280.0370.0347.545.0370.00.01906.60.97.0228.2125.94.32.40.2373
    Oncology
     Glucose metabolism18F-FDG5296.0555.0403.0100.2444.00.01907.71.98.4394.678.27.51.50.8804
    • ↵* Cyclomedica.

    • Min = minimum; Max = maximum; MUGA = multigated acquisition; RBC = red blood cell; MDP = methylene diphosphonate; DMSA = dimercaptosuccinic acid; MAG3 = mercaptoacetyltriglycine; MAA = macroaggregated albumin; HIDA = hepatobiliary iminodiacetic acid; HMPAO = hexamethylpropyleneamine oxime; ECD = ethyl cysteinate dimer.

    • View popup
    TABLE 2

    Effective Dose Difference Between Imaging Protocols for Combined Stress and Rest Myocardial Perfusion Studies

    Imaging protocolCenters (n)Mean effective dose (mSv)
    NaI(Tl) without resolution recovery tool1114.6 ± 2.3
    NaI(Tl) with resolution recovery tool516.7 ± 2.7
    IQ SPECT512.1 ± 1.6
    • View popup
    TABLE 3

    CTDI, DLP, and Effective Dose in Various CT Protocols Performed in SPECT/CT

    CTDI (mGy)DLP (mGy × cm)Effective dose (mSv)
    RegionSPECT/CT protocolAverageSDAverageSDAverageSD
    Neck and thorax (20 cm)Parathyroid study3.92.078.540.60.60.4
    Thorax (20 cm)Attenuation correction for myocardial study2.41.449.628.11.00.6
    Thorax (30 cm)67Ga-citrate for infection study2.71.283.437.21.81.2
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 46 (2)
Journal of Nuclear Medicine Technology
Vol. 46, Issue 2
June 1, 2018
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Effective Dose in Nuclear Medicine Studies and SPECT/CT: Dosimetry Survey Across Quebec Province
Mathieu Charest, Chantal Asselin
Journal of Nuclear Medicine Technology Jun 2018, 46 (2) 107-113; DOI: 10.2967/jnmt.117.202879
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Early 10-Minute Postinjection [18F]F-FAPI-42 uEXPLORER Total-Body PET/CT Scanning Protocol for Staging Lung Cancer Using HYPER Iterative Reconstruction
  • Single- Versus Dual-Time-Point Imaging for Transthyretin Cardiac Amyloid Using 99mTc-Pyrophosphate
  • Robustness of 18F-FDG PET Radiomic Features in Lung Cancer: Impact of Advanced Reconstruction Algorithm
Show more Imaging

Similar Articles

  • Effective Dose to Patients from SPECT and CT During Myocardial Perfusion Imaging
  • Radiation Dose Savings Associated with Personalized CT Scan Range in 18F-NaF Bone PET/CT
  • National Diagnostic Reference Levels for Nuclear Medicine in Kuwait
See more

Keywords

  • dosimetry
  • SPECT
  • SPECT/CT
  • conversion factor
  • Effective dose
  • Activity
SNMMI

© 2025 SNMMI

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effective Dose in Nuclear Medicine Studies and SPECT/CT: Dosimetry Survey Across Quebec Province
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Effective Dose in Nuclear Medicine Studies and SPECT/CT: Dosimetry Survey Across Quebec Province
Mathieu Charest, Chantal Asselin
Journal of Nuclear Medicine Technology Jun 2018, 46 (2) 107-113; DOI: 10.2967/jnmt.117.202879

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.